Cohen Cheryl's Form 4 filing
ImmunityBio, Inc. (IBRX) · filed Aug 19, 2021
- Accession no.
- 0001209191-21-052660
- Filed
- Aug 19, 2021
- Trade date
- Aug 17-18, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $460.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cohen CherylCIK 0001529371 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | Common Stock | SSaleDisposed | −43,398 | $10.12 | −$439,187.76 | 227,527 | Direct | |
| Aug 18, 2021 | Common Stock | SSaleDisposed | −2,133 | $10.03 | −$21,393.99 | 225,394 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.